Skip to content

Modeling Stress-precipitated Vaping Behavior

Modeling Stress-precipitated Vaping Behavior Among E-Cigarette Users

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04522362
Enrollment
51
Registered
2020-08-21
Start date
2017-10-25
Completion date
2018-06-30
Last updated
2020-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaping

Brief summary

The primary aims of this pilot study were to (1) initially validate the applicability of a human laboratory model of relapse initially developed for smokers to e-cigarette users; (2) to use this human laboratory model of lapse behavior to examine the effects of acute psychological stress on vaping-lapse behavior among adults who are experienced, e-cigarette users.

Interventions

OTHERControl task and Trier Social Stress Task

Same as Arm

Sponsors

University of Vermont
CollaboratorOTHER
Clemson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* at least 18 years old * e-cigarette users * using ≥1 mL of e-cigarette liquid per day with a nicotine concentration of ≥3mg/ml * had used an e-cigarette for at least three months

Exclusion criteria

* Current smokers * Psychiatric or medical condition based * Using a prescription medication other than birth control

Design outcomes

Primary

MeasureTime frameDescription
latency to initiate ad-lib vaping session (in minutes)During the two laboratory sessions which occur within 1 week after screening/baseline.Time to vaping during the vaping delay task. Range of time delay is 0 minutes to 50 minutes.
number of puffs purchased and consumed during the self-administration periodDuring the two laboratory sessions which occur within 1 week after screening/baselineNumber of e-cigarette uses purchased during the self-administration phase of the vaping delay task. Range of puffs is 0 to 20.

Secondary

MeasureTime frameDescription
CravingThe VAS will be collected at each laboratory session (within 1 week after screening/baseline) 5 times: baseline (pre task), post task (+15 minutes), decision to smoke (+20 minutes), +30 minutes smoking ab-lib, and +60 minutes during smoking ab-libCraving was measured using a visual analogue scale (VAS) asking How much do you crave an e-cigarette right now? with possible responses ranging from 0 (not at all) to 100 (extremely).
StressThe VAS will be collected at each laboratory session (within 1 week after screening/baseline) 5 times: baseline (pre task), post task (+15 minutes), decision to smoke (+20 minutes), +30 minutes smoking ab-lib, and +60 minutes during smoking ab-libStress was measured using a visual analogue scale (VAS) asking: How stressed or anxious do you feel right now? with possible responses ranging from 0 (not at all) to 100 (extremely).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026